As of May 3, 2025, Tenaya Therapeutics's market capitalization has reached $84.57 M. According to our data, Tenaya Therapeutics is the 24889th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
Tenaya Therapeutics has seen its market value drop from $782.28 M to $74.02 M since 2021, representing a total decrease of 90.54% and an annual compound decline rate (CAGR) of 51.01%.
Date
Market Cap
Change (%)
April 21, 2025
$74.02 M
-34.66%
December 31, 2024
$113.29 M
-48.67%
December 29, 2023
$220.68 M
71.58%
December 30, 2022
$128.62 M
-83.56%
December 31, 2021
$782.28 M
Company Profile
Tenaya Therapeutics was founded in 2016 in United States.
The company went public on July 30, 2021
on the Nasdaq Stock Market.
With 97 employees, it focuses on Healthcare and aims to drive innovation in Biotechnology.
Frequently Asked Questions
As of May 3, 2025, Tenaya Therapeutics (including the parent company, if applicable) has an estimated market capitalization of $84.57 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
Tenaya Therapeutics global market capitalization ranking is approximately 24889 as of May 3, 2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.